Abstract: Lower urinary tract symptoms (LUTS) and chronic prostatitis/chronic pelvic pain syndrome (CP/ CPPS) are common problems in men of all ages.
incontinence are more likely to host potentially pathogenic bacteria (e.g., Klebsiella, E. Coli, Bacteroides, Gardnerella, and Enterococcus) and less likely to have Lactobacillus and Corynebacterium species as constituents of their microbiome. Variations in microbiota have also been linked to differences in outcomes from pharmacotherapy (e.g., women with urge incontinence and less microbial diversity are more likely to respond to therapy with anticholinergics). Bladder sensation at urodynamics and incontinence are positively associated with presence of low level bacteriuria in women. Several small studies have investigated the urinary microbiome as a mediator of LUTS. Women with acutely worsened symptoms from pelvic pain are more likely to have yeast species identified in mid-stream urine. Men with chronic pelvic pain are more likely to harbor Burkholderia Cenocepacia in their initial voided urine although no differences were noted in mid-stream nor post-prostate massage urine. There tends be marked heterogeneity of the microbiome within groups, although this heterogeneity appears even more pronounced in patients with pelvic pain syndromes. Genes relevant to sporulation and chemotaxis are more heavily activated in pelvic pain patients whereas glycolysis, phosphotransferase, and pyruvate metabolism are less active when compared to healthy controls. Additional work will be required to carefully elucidate the presence, location, and scope of the putative urinary microbiome. Aside from taxonomic classification, assessment of functional gene assays will be essential; the presence of specific species may be less relevant than the presence of specific genes that up-or down-regulate host pathways that are germane to inflammation, nociception, infection-resistance, and other factors. Podium Lecture
